<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://singularityguide.de/news/nad-und-schlaf-wie-zellenergie-die-nachtruhe-beeinflusst-lkoj0</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-12T09:01:24.875+00:00</news:publication_date>
      <news:title>NAD+ und Schlaf: Wie Zellenergie die Nachtruhe beeinflusst</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/epigenetische-uhren-grenzen-biologischer-altermessung-lkea7</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-12T07:00:28.336+00:00</news:publication_date>
      <news:title>Epigenetische Uhren: Grenzen biologischer Altermessung</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/avride-nutzt-cloud-vlms-fuer-sichere-lieferroboter-tbgv3</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-12T05:00:27.775+00:00</news:publication_date>
      <news:title>Avride nutzt Cloud-VLMs für sichere Lieferroboter</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/ollama-acht-millionen-entwickler-nutzen-open-source-ki-plattform-ygqqg</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-11T15:01:17.173+00:00</news:publication_date>
      <news:title>Ollama: Acht Millionen Entwickler nutzen Open-Source-KI-Plattform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/altman-fordert-us-gefuehrtes-ki-regulierungsforum-gf928</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-11T13:01:23.338+00:00</news:publication_date>
      <news:title>Altman fordert US-geführtes KI-Regulierungsforum</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/nkgen-stellt-zelltherapie-gegen-alzheimer-vor-gez6x</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-11T11:00:27.784+00:00</news:publication_date>
      <news:title>NkGen stellt Zelltherapie gegen Alzheimer vor</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/ucl-und-eisai-verlaengern-alzhei-mer-forschung-bis-2030-ges6c</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-11T09:00:27.88+00:00</news:publication_date>
      <news:title>UCL und Eisai verlängern Alzhei­mer-Forschung bis 2030</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/neurosense-ein-wirkstoff-gegen-mehrere-hirnerkrankungen-3k2tg</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-11T07:00:28.222+00:00</news:publication_date>
      <news:title>NeuroSense: Ein Wirkstoff gegen mehrere Hirnerkrankungen?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/fountain-life-senkt-preis-longevity-fuer-unter-600-dollar-3jvkw</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-11T05:01:27.334+00:00</news:publication_date>
      <news:title>Fountain Life senkt Preis: Longevity für unter 600 Dollar</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/un-bericht-ki-regulierung-hinkt-entwicklung-hinterher-3jmc2</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-10T13:00:27.934+00:00</news:publication_date>
      <news:title>UN-Bericht: KI-Regulierung hinkt Entwicklung hinterher</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://singularityguide.de/news/nasa-testet-mars-rover-auf-dem-mond-qq6ke</loc>
    <news:news>
      <news:publication>
        <news:name>SINGULARITY GUIDE</news:name>
        <news:language>de</news:language>
      </news:publication>
      <news:publication_date>2026-07-10T11:00:27.897+00:00</news:publication_date>
      <news:title>NASA testet Mars-Rover auf dem Mond</news:title>
    </news:news>
  </url>
</urlset>